These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 7139430)
1. Is aminoglutethimide an alternative to adrenalectomy for metastatic carcinoma of the breast? Sterns EE; Bird CE; Mackie KW Can J Surg; 1982 Nov; 25(6):695-7. PubMed ID: 7139430 [TBL] [Abstract][Full Text] [Related]
2. A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer. Santen RJ; Worgul TJ; Samojlik E; Interrante A; Boucher AE; Lipton A; Harvey HA; White DS; Smart E; Cox C; Wells SA N Engl J Med; 1981 Sep; 305(10):545-51. PubMed ID: 7019703 [TBL] [Abstract][Full Text] [Related]
3. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses. Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205 [TBL] [Abstract][Full Text] [Related]
4. [Aminoglutethimide therapy in advanced breast cancer]. Kühböck J; Ludwig H; Pötzi P; Zielinski C Wien Med Wochenschr; 1985 Dec; 135(23-24):608-11. PubMed ID: 4096007 [TBL] [Abstract][Full Text] [Related]
5. Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen. Brufman G; Biran S Eur J Surg Oncol; 1985 Mar; 11(1):27-31. PubMed ID: 2985452 [TBL] [Abstract][Full Text] [Related]
6. [Results of hormone therapy with aminoglutethimide (Rodazol) in postmenopausal metastatic breast cancer]. Schmidt UM; Brockmann B; Geschke E Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):276-9. PubMed ID: 1713564 [TBL] [Abstract][Full Text] [Related]
7. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma. Samojlik E; Veldhuis JD; Wells SA; Santen RJ J Clin Invest; 1980 Mar; 65(3):602-12. PubMed ID: 6986409 [TBL] [Abstract][Full Text] [Related]
8. Cross-over comparison of tamoxifen and aminoglutethimide in advanced breast cancer. Harvey HA; Lipton A; White DS; Santen RJ; Boucher AE; Shafik AS; Dixon RJ Cancer Res; 1982 Aug; 42(8 Suppl):3451s-3453s. PubMed ID: 6177405 [TBL] [Abstract][Full Text] [Related]
9. [Aminoglutethimide in the treatment of metastasizing breast carcinoma in old age]. Gorgone S; Lorenzini C; Palmeri R; Belnome N; Calbo L; Dattola P; Melita P Chir Ital; 1987 Apr; 39(2):166-75. PubMed ID: 3652316 [TBL] [Abstract][Full Text] [Related]
10. Medical adrenalectomy with aminoglutethimide-cortisol in the treatment of metastatic breast carcinoma. Paridaens R; Van Haelen C; Heuson JC Eur J Cancer (1965); 1980; Suppl 1():103-6. PubMed ID: 7318860 [No Abstract] [Full Text] [Related]
11. Aminoglutethimide in the treatment of advanced postmenopausal breast cancer. Harris AL; Powles TJ; Smith IE Cancer Res; 1982 Aug; 42(8 Suppl):3405s-3408s. PubMed ID: 7083207 [TBL] [Abstract][Full Text] [Related]
12. Studies in patients with metastatic breast carcinoma treated with aminoglutethimide for medical adrenalectomy. Wells SA; Haagensen DE; Misbin R; Lipton A; Smart E; Santen RJ Surg Forum; 1976; 27(62):101-2. PubMed ID: 1019817 [No Abstract] [Full Text] [Related]
13. Aminoglutethimide in the treatment of metastatic breast cancer. Troner MB Cancer Res; 1982 Aug; 42(8 Suppl):3402s-3404s. PubMed ID: 7083206 [TBL] [Abstract][Full Text] [Related]
14. [Low-dose aminoglutethimide (500 mg/day) and hydrocortisone (30 mg/day) in advanced cancer of breast]. Bonneterre J; Pion JM; Demaille A Bull Cancer; 1987; 74(3):241-7. PubMed ID: 3304478 [TBL] [Abstract][Full Text] [Related]
15. [The use of aminoglutethimide in the treatment of metastatic breast cancer]. Bellora MG; Ciancio A; Ferrero A; Bergamino T; Zola P; Sismondi P Minerva Ginecol; 1991 Dec; 43(12):589-93. PubMed ID: 1819778 [TBL] [Abstract][Full Text] [Related]
16. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma. Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525 [TBL] [Abstract][Full Text] [Related]
17. Aminoglutethimide in tamoxifen-resistant patients: The Melbourne Experience. Murray RM; Pitt P Cancer Res; 1982 Aug; 42(8 Suppl):3437s-3441s. PubMed ID: 6211229 [TBL] [Abstract][Full Text] [Related]
18. Aminoglutethimide as second line endocrine therapy in advanced breast cancer. Brufman G; Biran S Anticancer Res; 1986; 6(5):1065-8. PubMed ID: 3800315 [TBL] [Abstract][Full Text] [Related]
19. [Chemical adrenalectomy induced by aminoglutethimide in the treatment of breast cancer. A review]. Cikes M Schweiz Med Wochenschr; 1983 Mar; 113(11):382-91. PubMed ID: 6342129 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of metastasizing breast cancer with aminoglutethimide]. Kübböck J; Ludwig H; Aiginger P; Linkesch W; Pötzi P Acta Med Austriaca; 1982; 9(5-6):221-6. PubMed ID: 7164757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]